1. http://www.cancer.gov/clinicaltrials/search/view?cdrid=648267&version=HealthProfessional&protocolsearchid=6994018 . Accessed 13 Feb 2012
2. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M (2005) EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 16:63–275
3. Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–398
4. Ali I, Rahisuddin SK, Haque A, El-Azzouny A (2010) Natural products: human friendly anticancer medications. Egypt Pharma J 9:133–179
5. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818